Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia
Recruiting now · Phase 1/Phase 2
Conditions studied: Thalassemia in Children
In brief
The purpose of this study is to evaluate a novel transplant strategy for the long-term benefit of patients with transfusion dependent high-risk thalassemia.
Key facts
- Study ID
- NCT05426252
- Run by
- The Hospital for Sick Children
- People needed
- 20
- Starts
- 2022-03-22
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2023-12-19
Who can join
Age: 1 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Yogi Chopra — Toronto, Ontario, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.